| Similar Articles |
|---|
 |
IDB America
February 2002
Charo Quesada |
The fruits of foresight An architect of Brazil's AIDS program describes the "critical and innovative vision" that led to success...   |
IDB America
September 2001
Charo Quesada |
Against the odds Brazil emerges as a role model in the fight against AIDS... |
American Journal of Nursing
March 2010
David E. Vance |
Aging with HIV: Clinical Considerations for an Emerging Population Since the advent of highly active antiretroviral therapy, HIV infection has become a chronic, albeit life-threatening, condition that can be managed; therefore, more and more people are growing older with HIV. |
Nursing
January 2011
Carl A. Kirton |
HIV: The Changing Epidemic Since its emergence in the early 1980s, HIV infection in the United States has evolved from an acute debilitating condition to a chronic, treatable illness. |
BusinessWeek
February 10, 2011
Rob Waters |
Sangamo's Bet Against AIDS: Gene Therapy Sangamo's stock has more than doubled since July 6, when the company, with no products on the market, reported success of its gene therapy approach in mice in the journal Nature Biotechnology. |
BusinessWeek
April 1, 2010
Bennett & Randall |
Will an AIDS Pill a Day Keep the Virus Away? Drugmaker Gilead is betting the one-pill PrEP treatment will slow the virus' spread - as are some of the world's top health agencies and philanthropists. |
BusinessWeek
September 2, 2010
Simeon Bennett |
David Margolis' Fight to End AIDS The North Carolina professor is relying on Zolinza, a rarely used Merck cancer drug, to stamp out AIDS. |
BusinessWeek
August 5, 2010
Bennett & Randall |
AIDS Drugs Flow to the Third World Drugmakers, once blasted for their practices, are slashing prices and licensing AIDS drugs for free to nonprofits or local manufacturers in developing countries. |
American Journal of Nursing
March 2010
Bradley-Springer et al. |
Every Nurse Is an HIV Nurse The evolution of HIV infection into a chronic disease has implications across all clinical care settings. Every nurse should be knowledgeable about the disease in order to provide high-quality care to people with or at risk for HIV. |
The Motley Fool
March 31, 2011
Brian Orelli |
Hepatitis C Drugs Heat Up The current hepatitis C drugs stink. Who's ahead in the race to find new ones? |
Pharmaceutical Executive
February 1, 2012 |
Brazil Report: A Bold Player Blooms Brazil was the last country to enter the fiscal crisis, but also the first to exit. And with a burgeoning middle class and a staunch commitment to national development, its pharmaceutical future is now. |
The Motley Fool
April 26, 2007
Brian Lawler |
Brazil's Boneheaded Drug Move Brazil already receives a steep discount on the price that Merck charges it for its HIV compounds. Nevertheless, it wants still lower prices to help reduce the government's costs associated with supplying drugs to those living with HIV/AIDS. |
IDB America
February 2002
Charo Quesada |
A historical commitment in a challenged region The nations of the Caribbean confront HIV/AIDS... |
Salon.com
May 1, 2001
Daryl Lindsey |
Amy and Goliath A first-year law student brought a giant pharmaceutical to its knees. But will her victory for South Africa's AIDS sufferers deprive the world of new medicines? |
Pharmaceutical Executive
October 1, 2011 |
Patient Advocacy: The Last 30 Years The rise of advocacy groups has helped patients find their voice, but the power to change health profiles remains an elusive goal. |
IDB America
September 2001
Charo Quesada |
The cost of silence The executive director of UNAIDS urges Latin America and the Caribbean to break the silence surrounding AIDS if they wish to avert greater tragedy... |
Finance & Development
March 1, 2002
Robert Hecht |
Making AIDS Part of the Global Development Agenda AIDS is not just a health issue but a development problem that must be addressed at the global level. As countries increasingly recognize the need to incorporate strategies for tackling AIDS in their national policy frameworks, they are looking at new national poverty reduction plans... |
BusinessWeek
August 2, 2004
Arnst & Einhorn |
Why Business Should Make AIDS Its Business Some multinational companies are taking baby steps to control the AIDS in their workforce, but more needs to be done. |
Pharmaceutical Executive
June 1, 2014
Jill Wechsler |
Compassionate Use Requests Complicate Drug Development Pharma, HCPs, and regulators walk tightrope in addressing early-access push while supporting biomedical R&D. |
The Motley Fool
December 14, 2006
Stephen Albainy-Jenei |
Merck Gets Punk'd by Thailand Thailand issues a compulsory license to manufacture a generic version of Merck's patented AIDS drug. This is an act of humanitarian aid, but it is also an avenue for price and profit erosion worldwide. |
ifeminists
July 28, 2004
Wendy McElroy |
AIDS Efforts Undermined by U.N. Politics Politics lies at the root of the U.N.'s constant bashing of American policies. In the shifting vista of AIDS politics, where even the figures are blurring, the U.S. is correct and prudent to withhold its support. |
Salon.com
June 1, 2001
Daryl Lindsey |
The AIDS-drug warrior Outspoken AIDS-drug activist Jamie Love says pharmaceutical companies must be forced to yield their patents to save hundreds of thousands of lives. Is he a visionary -- or a dangerous radical? |
The Motley Fool
September 29, 2011
Brian Orelli |
Are HIV Drugmakers Doomed? Generics are a bigger threat than Sangamo for now. |
Chemistry World
May 23, 2006
Katharine Sanderson |
Brazil and UK Team up Brazil is ready and mature to join the international science arena, the Brazilian science minister told leading UK and Brazilian scientists and politicians yesterday. |
Salon.com
May 18, 2000
Sabin Russell |
The dream and the coming disaster AIDS threatens to ravage the hopes of South Africa's young democracy. Don't expect leaders to get excited because a few companies cut the cost of HIV drugs. |
The Motley Fool
January 21, 2010
Brian Orelli |
Here's That Critical Merck Info You Missed Announcing clinical trial failures in a FAQ? Really? |
Financial Planning
February 1, 2010
David E. Adler |
Decisions, Decisions Are you sure, really sure, that clients understand your explanations? That they make choices for the right reasons? Surprise-healthcare has an answer. |
Salon.com
May 8, 2001
Daryl Lindsey |
The "Joe Camel" ads of AIDS? The FDA says ads for drugs to suppress HIV are making false promises, and could be contributing to an epidemic of unsafe sex... |
Salon.com
August 21, 2001
David Horowitz |
The AIDS obstructionists As the AIDS epidemic spins out of control, special interest groups are preventing one of the only things that can work -- mandatory testing... |
Salon.com
July 13, 2000
Megan Williams |
African mothers: Save us, too AIDS activists say providing drugs to prevent HIV transmission to babies but not treating their mothers is unconscionable. |
Salon.com
July 17, 2000
Nina Teicholz |
When drugs take a holiday Could taking a break from protease inhibitors be the secret to treating AIDS? A new case of a 40-year-old man in Philadelphia shows it's possible. |
Salon.com
June 26, 2001
Daryl Lindsey |
AIDS conclave off to rocky start A gay rights group gets included in the end, but members split over whether -- and how -- to talk about homosexuality when crafting a response to the disease... |
IDB America
September 2001
Charo Quesada |
AIDS emerges from the shadows Unless countries act now, the epidemic will become uncontrollable... |
Bio-IT World
May 7, 2002
Davies & Levitt |
Bridge Over Troubled Waterford Project For a project that links some of the best institutions and minds in AIDS research in order to produce an effective vaccine that could save millions of lives, funding should be a nonissue. Unfortunately, that is not the case -- and the bio-IT community has to find a way to remedy this issue. |
Chemistry World
July 11, 2012 |
Gsk Drug Shines in HIV Trial GlaxoSmithKline has announced good results for its HIV - Aids drug candidate dolutegravir, which has apparently outperformed Atripla tablets in Phase III. |
Wired
November 2004
Julian Dibbell |
We Pledge Allegiance to the Penguin We pledge allegiance to the penguin, and the intellectual property regime for which he stands. One nation, under Linux, with free music and open source software for all. Welcome to Brazil! |
IDB America
January 2003
Daniel Drosdoff |
Reaping the fruits of fiscal reform In exchange for financial discipline and transparency, Brazil's states and municipalities get more control over their budgets |
Salon.com
July 28, 2000
Kate Scanell |
Contributing to genocide By giving HIV deniers a global platform, South African President Mbeki has put countless lives at risk. |
Mother Jones
August 2000
Jacob Levenson |
A Time for Healing African Americans now account for the majority of new AIDS cases. But a crusading Harlem pastor believes the black church can slow the epidemic's spread. |
Pharmaceutical Executive
August 1, 2013
Joseph Saba |
New Rules for a New Africa Declining revenue growth in the United States and Europe have sent pharmaceutical companies in search of opportunities in the BRICs and other emerging economies. Now, companies are finally turning their attention to Africa. |
Pharmaceutical Executive
April 1, 2012
Feam & Lagus |
Providing Access Now While regulatory frameworks and medical practices differ between countries, many patients still need early access to new drugs. Industry can help. |
The Motley Fool
December 5, 2011
Alexander Crawford |
Ending HIV/AIDS: Hedge Funds Believe in These 5 Companies Do you think these companies will contribute to a cure? |
Pharmaceutical Executive
October 1, 2010 |
Optimizing TV Advertising Placements & Results Brand managers choosing to advertise an anti-depressant on "Criminal Minds" may not be making the best choice. New methodologies reveal "Law & Order: Special Victims Unit" along with "The Bachelor" to be shows favored by depressives. |
AskMen.com
Dave Golokhov |
Truvada With more and more studies finding successful AIDS prevention, it looks like we're getting closer to finding a cure. |
Nursing
August 2008
Carl A. Kirton |
Managing Long-Term Complications of HIV Infection Now that advances in treatment have transformed HIV into a chronic, manageable disease, patients are facing cardiovascular and metabolic complications you might not have expected 15 years ago. Here's how to help your patient manage them. |
Salon.com
June 27, 2001
Daryl Lindsey |
A pandemic fueled by poverty A doctor says the fight to get cheap AIDS drugs to Africa is misguided: These people need water, food and basic healthcare... |
Bank Technology News
June 2002
Daniel A. Joelson |
Unibanco Showcases Brazil's Security Technology Drive The Brazilian banking giant is making great strides in its effort to cut criminal activity.. |
IDB America
April 2008
Paul Constance |
Start with a Motion Sensor Biofuels get all the attention, but Brazil's energy policy succeeds thanks to efficiency, diversity and innovation. |
American Family Physician
July 15, 2001
Sweeney & Neff |
Newsletter HHS Releases a Clinical Guide on the Treatment of Women with HIV... CSAT Offers Grants for Rural Drug Treatment Centers... Federal Agencies Mark 20th Anniversary of First AIDS Case... New Web Site Provides Information on Food-borne Illnesses... NIH Establishes National Family Registry for Scleroderma... |
Reason
April 2001
Ronald Bailey |
Goddamn the Pusher Man Why does everybody seem to hate the pharmaceutical industry? |
